Publications

Phase 2 Open-Label Extension Study Of Patisiran, An Investigational Rnai Therapeutic For The Treatment Of Familial Amyloid Polyneuropathy

AuthID
P-00G-XDC

Author(s)

Adams, D

Suhr, O

Conceicao, I

Waddington Cruz, M

Buades, J

Pouget, J

Document Type

Abstract

Year published

2015

Published

in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, ISSN: 0022-3050

Volume: 86, Issue: 11, Pages: e4.115-e4 (1)

Conference

Annual Meeting of the Association-Of-British-Neurologists (Abn), Date: SEP 10, 2015, Location: Inst Educ, London, ENGLAND, Sponsors: Assoc British Neurologists, Host: Inst Educ

Indexing

Wos^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1136/jnnp-2015-312379.27

Wos: WOS:000364994100028

Source Identifiers

ISSN: 0022-3050

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Phase 2 Open-Label Extension Study Of Patisiran, An Investigational Rnai Therapeutic For The Treatment Of Familial Amyloid Polyneuropathy

Useful Links

Get Help

Federated Authentication (Click on the image)

Phase 2 Open-Label Extension Study Of Patisiran, An Investigational Rnai Therapeutic For The Treatment Of Familial Amyloid Polyneuropathy

Useful Links

Get Help